Status:
COMPLETED
Effects of a Physical Exercise Program in Quality of Life of Breast Cancer Survivors
Lead Sponsor:
Associacao de Investigacao de Cuidados de Suporte em Oncologia
Collaborating Sponsors:
Centro Hospitalar de Vila Nova de Gaia/Espinho
Aveiro University
Conditions:
Breast Cancer
Quality of Life
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
A 16 weeks 3-weekly supervised and adapted physical exercise program will be applied to breast cancer survivors in surveillance and, in estrogen receptor positive cases, under hormonotherapy. The prog...
Detailed Description
This protocol describes a two-arm prospective non randomized trial that will test the HRQoL effect of a 16 weeks 3-weekly supervised and adapted physical exercise program that combines muscle strength...
Eligibility Criteria
Inclusion
- Histological diagnosis of breast carcinoma
- Stages 0 to IIIC
- Having undergo primary treatment with curative intent, defined as surgery that can have been complemented with neoadjuvant, or adjuvant, chemotherapy and/or radiotherapy
- Conclusion of the last of the following treatments at least one month before: surgery, chemotherapy or radiotherapy
- At least one consultation in the Medical Oncology Department of the Centro Hospitalar de Vila Nova de Gaia/Espinho
- Assistant medical oncologist consent for the physical exercise practice
- Not meeting the physical activity guidelines of the American College of Sports Medicine (moderate activity ≥ 150 minutes/week ou vigorous activity ≥ 75 minutes/week and ≥ 2 resistance training/week).
Exclusion
- Severe anemia (Hb ≤ 8 g/dL)
- Symptomatic moderate anemia (Hb \>8 and ≤ 10 g/dL); considered symptoms are: sustained tachycardia, exertion dyspnea, thoracic pain or syncope
- Uncontrolled hypertension
- Uncontrolled diabetes
- Cardiac failure grade \>1 in the New York Heart Association evaluation
- History of osteoporosis with Tscore \<-2.5 in the lumbar spine and/or femur in the menopause
- Contraindication given by the assistant surgeon
Key Trial Info
Start Date :
July 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04024280
Start Date
July 1 2018
End Date
January 1 2022
Last Update
February 16 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro Hospitalar de Vila Nova de Gaia/Espinho
Vila Nova de Gaia, Porto District, Portugal, 4434-502 Vila Nova de Gaia